Risk factors for lung disease progression in children with cystic fibrosis; a longitudinal cohort study

K. van de Kant (Maastricht, Netherlands)

Source: International Congress 2017 – Cystic fibrosis: treatments and monitoring
Session: Cystic fibrosis: treatments and monitoring
Session type: Poster Discussion
Number: 1827
Disease area: Airway diseases, Paediatric lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
K. van de Kant (Maastricht, Netherlands). Risk factors for lung disease progression in children with cystic fibrosis; a longitudinal cohort study. 1827

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Risk factors for lung disease progression in children with cystic fibrosis
Source: Eur Respir J, 51 (6) 1702509; 10.1183/13993003.02509-2017
Year: 2018



Risk factors for lung disease progression in children with cystic fibrosis
Source: Eur Respir J, 52 (4) 1801492; 10.1183/13993003.01492-2018
Year: 2018



Risk factors for progression of cystic fibrosis lung disease from childhood to adulthood
Source: Virtual Congress 2020 – Respiratory diseases in children and adults
Year: 2020


Prevalence and characteristics of cystic lung lesions in children with interstitial lung diseases – a register-based study
Source: Virtual Congress 2021 – Paediatric bronchology
Year: 2021



Early markers of cystic fibrosis structural lung disease: follow-up of the ACFBAL cohort
Source: Eur Respir J, 55 (4) 1901694; 10.1183/13993003.01694-2019
Year: 2020



Screening for cystic fibrosis among high risk group patients with chronic lung disease
Source: Eur Respir J 2002; 20: Suppl. 38, 340s
Year: 2002

Risk factors for postoperative acute exacerbation of interstitial lung diseases: a matched case-control study
Source: International Congress 2019 – Rare and ultra-rare diseases and the lungs: updates and new perspectives
Year: 2019



Factors affecting progression of lung disease among patients with cystic fibrosis
Source: International Congress 2019 – Physiology of cystic fibrosis
Year: 2019


Does the lung clearance index track with disease progression in early childhood?
Source: International Congress 2015 – Cystic fibrosis: physiology, biomarkers, microbiology and miscellaneous
Year: 2015


Survival estimates in European cystic fibrosis patients and the impact of socioeconomic factors: a retrospective registry cohort study
Source: Eur Respir J, 58 (3) 2002288; 10.1183/13993003.02288-2020
Year: 2021



Early deaths in cystic fibrosis: Analysis of causes and risk factors in a pediatric cohort
Source: Annual Congress 2012 - Cystic fibrosis (adults and children): risk factors and clinical problems
Year: 2012

Early determinants of lung disease in children with cystic fibrosis
Source: Virtual Congress 2020 – New frontiers in cystic fibrosis imaging and lung physiology
Year: 2020




CF disease progress regarding lung symptoms – a cohort study
Source: Annual Congress 2007 - Cystic fibrosis lung disease: what do we measure? What do we know?
Year: 2007


Prospective evaluation of cardio-metabolic comorbidities in a cohort of patients with non-cystic fibrosis bronchiectasis.
Source: Virtual Congress 2020 – Interesting clinical problems for the respiratory physician
Year: 2020


Nutrition-related factors associated with waiting list mortality in patients with interstitial lung disease: a retrospective cohort study
Source: International Congress 2019 – Lung transplantation: from bench to bedside
Year: 2019


Occupational risk factors and idiopathic pulmonary fibrosis. A case-control study
Source: Annual Congress 2007 - The air we breathe at home and at work
Year: 2007


An observational study of incident diagnoses of children’s diffuse parenchymal lung disease (ChILDEU)
Source: International Congress 2018 – Primary ciliary dyskinesia and lung function tests in respiratory morbidities
Year: 2018


Longitudinal assessment of Lung Clearance Index as a marker of disease progression in a cohort of children with cystic fibrosis and normal spirometry
Source: Virtual Congress 2020 – New frontiers in cystic fibrosis imaging and lung physiology
Year: 2020




Impact of other risk factors than age at diagnosis on outcome in cystic fibrosis patients
Source: Eur Respir J 2006; 28: Suppl. 50, 715s
Year: 2006

Prospective cohort study of the alternate healthy eating index-2010 and risk of chronic obstructive pulmonary disease in US women and men
Source: Annual Congress 2013 –Environment and lifestyle: associations with respiratory disease
Year: 2013